By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Veracyte, Inc. 

6000 Shoreline Court

South San Francisco  California  94080  U.S.A.
Phone: 650-243-6300 Fax: 650-243-6301



Company News
Multiple Studies Presented At ENDO 2017 Support Use Of Veracyte (VCYT)'s Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis 4/4/2017 8:52:47 AM
Veracyte (VCYT) Announces Fourth Quarter And Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 3/2/2017 8:56:01 AM
Veracyte (VCYT) Announces Executive Promotions 3/1/2017 8:18:19 AM
Veracyte (VCYT) Announces Publication Of Data Demonstrating Potential For Non-Invasive Nasal Test To Improve Lung Cancer Diagnosis 2/27/2017 8:30:19 AM
Veracyte (VCYT): An Ideal Medium-Term Runner With Long-Term Upside 2/27/2017 6:11:54 AM
Veracyte (VCYT) Announces Ten New Blues Plan Coverage Policies For Its Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis 2/21/2017 9:00:11 AM
Veracyte (VCYT) To Expand Patient Access To The Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics (DGX) 2/8/2017 8:52:56 AM
Veracyte (VCYT) Announces Final Medicare Coverage Policies For Percepta Bronchial Genomic Classifier 2/6/2017 7:01:33 AM
Veracyte (VCYT) Announces Appointment Of Kevin K. Gordon And Other Changes To Its Board Of Directors 12/13/2016 7:16:45 AM
Veracyte (VCYT) Announces That Centers for Medicare & Medicaid Services Will Maintain Historic Medicare Reimbursement Rate For The Afirma Gene Expression Classifier In 2017 11/22/2016 9:07:22 AM